A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)

Mostrar otras versiones (1)

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) global pandemic has had a profound, lasting impact on the world's population. A key aspect to providing care for those with COVID-19 and checking its further spread is early and accurate diagnosis of infection, which has been generally done vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajczewski, Andrew T., Mehta, Subina, Nguyen, Dinh Duy An, Grüning, Björn, Johnson, James E., McGowan, Thomas, Griffin, Timothy J., Jagtap, Pratik D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107781/
https://www.ncbi.nlm.nih.gov/pubmed/33971807
http://dx.doi.org/10.1186/s12014-021-09321-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107781/
https://www.ncbi.nlm.nih.gov/pubmed/33971807
http://dx.doi.org/10.1186/s12014-021-09321-1

Ejemplares similares